China Resources Pharmaceutical Group Limited

HKEX:3320.HK

5.55 (HKD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019201820172016201520142013
Revenue 270,397.302254,106.366236,806.169200,423.023204,453.869189,689.107172,532.204156,705.203146,568.105135,749.18116,950.696
Cost of Revenue 227,030.95214,971.606201,425.883168,129.162170,436.179154,758.728144,256.056132,596.104123,369.243114,259.15896,801.611
Gross Profit 43,366.35239,134.7635,380.28632,293.86134,017.6934,930.37928,276.14824,109.09923,198.86221,490.02220,149.085
Gross Profit Ratio 0.160.1540.1490.1610.1660.1840.1640.1540.1580.1580.172
Reseach & Development Expenses 02,089.5181,688.5511,317.9641,154.2931,039.28908.176789.416781.144944.794730.617
General & Administrative Expenses 6,328.1666,478.5846,227.6475,563.1525,203.7684,703.6064,201.7373,882.1863,844.8924,246.7733,673.505
Selling & Marketing Expenses 18,909.89819,033.09617,530.716,029.44519,188.52318,340.8813,868.78510,947.47910,111.5468,800.1548,423.115
SG&A 25,238.06426,232.76324,442.88922,505.34524,838.67823,134.30918,115.86414,829.66513,956.43813,046.92712,096.62
Other Expenses 0-1,726.747-1,399.833-558.491706.1467.245451.395311.619-211.843.571304.302
Operating Expenses 30,442.1628,322.28126,131.4423,823.30925,992.97123,269.58917,877.49814,308.44713,287.77413,046.92712,096.62
Operating Income 11,920.68510,812.4799,248.8468,470.5528,024.71910,444.229,287.4958,322.9327,879.2678,851.0698,513.905
Operating Income Ratio 0.0440.0430.0390.0420.0390.0550.0540.0530.0540.0650.073
Total Other Income Expenses Net -2,040.458-2,451.398-2,375.831-2,507.661-3,797.831-3,693.846-2,503.002-1,121.502-1,837.636-3,315.34-3,112.107
Income Before Tax 9,880.2279,467.0698,094.8356,868.6566,499.1519,182.4778,582.3488,042.6658,050.2956,922.7736,912.913
Income Before Tax Ratio 0.0370.0370.0340.0340.0320.0480.050.0510.0550.0510.059
Income Tax Expense 2,105.2242,012.4021,761.0261,751.8671,541.7651,610.1531,715.4822,074.5761,968.0611,430.9021,458.286
Net Income 3,854.2473,500.273,080.6732,778.6563,286.4194,037.893,483.0362,821.412,850.0762,645.942,639.517
Net Income Ratio 0.0140.0140.0130.0140.0160.0210.020.0180.0190.0190.023
EPS 0.680.660.60.520.520.640.550.570.620.430.43
EPS Diluted 0.680.660.60.520.520.640.550.570.620.430.43
EBITDA 15,430.90415,473.21211,945.77912,465.98212,576.39913,656.34110,739.219,950.799,146.7378,324.3967,719.787
EBITDA Ratio 0.0570.0550.0510.0540.0510.0630.0620.0610.0620.0750.083